A higher frequency of PIK3CA mutations in mixed DCIS (8 out of 33, 24 %) than in pure DCIS (0 out of 31) has been reported in a specific group of high-grade, estrogen receptor-positive, HER2-negative DCIS cases [72]. The gene discussed is ESR1; the disease is ductal breast carcinoma in situ.